stockportfolio.pro
Amphastar Pharmaceuticals, Inc. Gross Profit 2012–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual gross profit by fiscal year, computed from SEC filings. Compound growth +11.1%/yr over 13 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $356.06M | 49.5% | -4.8% |
| FY 2024 | $373.86M | 51.1% | +6.5% |
| FY 2023 | $351.12M | 54.5% | +41.1% |
| FY 2022 | $248.86M | 49.9% | +24.6% |
| FY 2021 | $199.74M | 45.6% | +39.3% |
| FY 2020 | $143.34M | 41.0% | +8.7% |
| FY 2019 | $131.92M | 40.9% | +23.3% |
| FY 2018 | $106.98M | 36.3% | +18.2% |
| FY 2017 | $90.51M | 37.7% | -13.1% |
| FY 2016 | $104.20M | 40.8% | +34.7% |
| FY 2015 | $77.35M | 30.8% | +50.9% |
| FY 2014 | $51.26M | 24.4% | -41.1% |
| FY 2013 | $86.96M | 37.9% | -3.7% |
| FY 2012 | $90.30M | 44.2% | — |
Source: Amphastar Pharmaceuticals, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Amphastar Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAmphastar Pharmaceuticals, Inc. — frequently asked questions
What is Amphastar Pharmaceuticals, Inc.'s gross profit?
Amphastar Pharmaceuticals, Inc. (AMPH) reported gross profit of $356.06M for fiscal year 2025, per its SEC filings.
How has Amphastar Pharmaceuticals, Inc.'s gross profit changed over time?
Between fiscal 2012 and 2025, AMPH's gross profit grew at roughly 11.1% per year (compound annual rate), from $90.30M to $356.06M.
Where does this data come from?
Figures are computed from Amphastar Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.